Literature DB >> 16902193

Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens.

Soren Hansen1, Bernice Lo, Kathy Evans, Pavlos Neophytou, Uffe Holmskov, Jo Rae Wright.   

Abstract

Surfactant protein D (SP-D) is a secreted pattern recognition molecule associated with lung surfactant and mediates the clearance of pathogens in multiple ways. SP-D is an established part of the innate immune system, but it also modulates the adaptive immune response by interacting with both antigen-presenting cells and T cells. In a previous study, antigen presentation by bone marrow-derived dendritic cells was enhanced by SP-D. As dendritic cell function varies depending on the tissue of origin, we extended these studies to antigen-presenting cells isolated from mouse lung. Flow cytometric studies showed that SP-D binds calcium dependently and specifically to lung CD11c-positive cells. Opsonization of fluorescently labeled Escherichia coli by SP-D enhanced uptake by lung dendritic cells. SP-D facilitated the association of E. coli and antigen-presenting cells by increasing the frequency of CD11+ cells associated with E. coli by up to 10-fold. In contrast to the effect on bone marrow-derived dendritic cells, SP-D decreased the antigen presentation of ovalbumin, expressed in E. coli, to ovalbumin-specific major histocompatibility complex class II-specific T-cell hybridomas by 30-50%. The reduction of antigen presentation did not depend on whether the dendritic cells were isolated from the lungs of nonstimulated mice or mice that had been exposed to LPS aerosols. Our results show that SP-D increases the opsonization of pathogens, but decreases the antigen presentation by lung dendritic cells, and thereby, potentially dampens the activation of T cells and an adaptive immune response against bacterial antigens--during both steady-state conditions and inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902193      PMCID: PMC1899304          DOI: 10.1165/rcmb.2006-0195OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  49 in total

1.  Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.

Authors:  M Svensson; B Stockinger; M J Wick
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

2.  Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors.

Authors:  K Garrigan; P Moroni-Rawson; C McMurray; I Hermans; N Abernethy; J Watson; F Ronchese
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

3.  Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule.

Authors:  U Holmskov; P Lawson; B Teisner; I Tornoe; A C Willis; C Morgan; C Koch; K B Reid
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

4.  Degradation of surfactant protein D by alveolar macrophages.

Authors:  Q Dong; J R Wright
Journal:  Am J Physiol       Date:  1998-01

5.  CD14 is expressed by subsets of murine dendritic cells and upregulated by lipopolysaccharide.

Authors:  K Mahnke; E Becher; P Ricciardi-Castagnoli; T A Luger; T Schwarz; S Grabbe
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

6.  Surfactant protein D is proatherogenic in mice.

Authors:  Grith L Sorensen; Jens Madsen; Karin Kejling; Ida Tornoe; Ole Nielsen; Paul Townsend; Francis Poulain; Claus H Nielsen; Kenneth B M Reid; Samuel Hawgood; Erling Falk; Uffe Holmskov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-12-30       Impact factor: 4.733

7.  Surfactant protein A-deficient mice are susceptible to group B streptococcal infection.

Authors:  A M LeVine; M D Bruno; K M Huelsman; G F Ross; J A Whitsett; T R Korfhagen
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

8.  Development of a procedure for the direct cloning of T-cell epitopes using bacterial expression systems.

Authors:  P I Neophytou; P Ozegbe; D Healey; R Quartey-Papafio; A Cooke; J C Hutton
Journal:  J Immunol Methods       Date:  1996-09-13       Impact factor: 2.303

9.  Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D.

Authors:  C Botas; F Poulain; J Akiyama; C Brown; L Allen; J Goerke; J Clements; E Carlson; A M Gillespie; C Epstein; S Hawgood
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

10.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.

Authors:  F Sallusto; M Cella; C Danieli; A Lanzavecchia
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Therapeutic use of surfactant components in allergic asthma.

Authors:  Veit J Erpenbeck; Norbert Krug; Jens M Hohlfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

2.  Surfactant protein D (SP-D) deficiency is attenuated in humanised mice expressing the Met(11)Thr short nucleotide polymorphism of SP-D: implications for surfactant metabolism in the lung.

Authors:  Lars Knudsen; Katharina Ochs; Laura Boxler; Ida Tornoe; Grith Lykke-Sorensen; Rose-Marie Mackay; Howard W Clark; Uffe Holmskov; Matthias Ochs; Jens Madsen
Journal:  J Anat       Date:  2013-09-23       Impact factor: 2.610

Review 3.  Macrophage immunoregulatory pathways in tuberculosis.

Authors:  Murugesan V S Rajaram; Bin Ni; Claire E Dodd; Larry S Schlesinger
Journal:  Semin Immunol       Date:  2014-10-30       Impact factor: 11.130

4.  Dispensability of surfactant proteins A and D in immune control of Mycobacterium tuberculosis infection following aerosol challenge of mice.

Authors:  Maria P Lemos; John McKinney; Kyu Y Rhee
Journal:  Infect Immun       Date:  2011-01-03       Impact factor: 3.441

5.  Lung effector memory and activated CD4+ T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation.

Authors:  Amy M Pastva; Sambuddho Mukherjee; Charles Giamberardino; Bethany Hsia; Bernice Lo; Gregory D Sempowski; Jo Rae Wright
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

Review 6.  Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.

Authors:  Michael Schivo; Timothy E Albertson; Angela Haczku; Nicholas J Kenyon; Amir A Zeki; Brooks T Kuhn; Samuel Louie; Mark V Avdalovic
Journal:  J Investig Med       Date:  2017-03-03       Impact factor: 2.895

Review 7.  Review: Collectins link innate and adaptive immunity in allergic airway disease.

Authors:  Julie G Ledford; Amy M Pastva; Jo Rae Wright
Journal:  Innate Immun       Date:  2010-04-23       Impact factor: 2.680

8.  Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice.

Authors:  Kendra Gram; Shuxia Yang; Marie Steiner; Arif Somani; Samuel Hawgood; Bruce R Blazar; Angela Panoskaltsis-Mortari; Imad Y Haddad
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-07       Impact factor: 5.464

9.  Surfactant protein D inhibits TNF-alpha production by macrophages and dendritic cells in mice.

Authors:  László Hortobágyi; Sonja Kierstein; Kateryna Krytska; Xiaoping Zhu; Anuk M Das; Francis Poulain; Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2008-06-12       Impact factor: 10.793

Review 10.  Immunomodulatory roles of surfactant proteins A and D: implications in lung disease.

Authors:  Amy M Pastva; Jo Rae Wright; Kristi L Williams
Journal:  Proc Am Thorac Soc       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.